RESEARCH TRIANGLE PARK –Vestaron, a company developing biopesticides for targeted, safe, and efficient crop protection, has raised $18 million in an oversubscribed B-1 financing,
Northpond Ventures led the round. Northpond and additional new investor, Cavallo Ventures, the venture arm of Wilbur-Ellis, join continuing investors Novo Holdings, Syngenta Ventures, CGC Ventures, and Anterra Capital.
The company moved its corporate headquarters to Research Triangle Park from Kalamazoo, Michigan, in 2019. It previously raised a $40 million B round from an impressive investor syndicate.
Peptides (small proteins) have the same proven modes of action (a nerve and muscular attack) and the same efficacy as traditional synthetics but with the safety and environmental friendliness of biologics.
Share this article
Share this article
RESEARCH TRIANGLE PARK, N.C., Feb. 16, 2021 /PRNewswire/ Vestaron, a company dedicated to improving the safety, efficacy and sustainability of crop protection through its development of peptide-based biopesticides, announces $18 million in Series B-1 financing, led by Northpond Ventures. Northpond and additional new investor, Cavallo Ventures, the venture arm of Wilbur-Ellis, join continuing investors Novo Holdings, Syngenta Ventures, CGC Ventures and Anterra Capital in this round. Adam Wieschhaus, Director at Northpond Ventures, will join the Vestaron Board of Directors.
With its proprietary platform for the optimization, production and delivery of peptide-based biopesticides, Vestaron is leading the development of a novel class of crop protection products – peptides (small proteins). These peptides have the proven modes of action and thus the same efficacy as traditional synthetics with the safety and environmental friendliness of biolog